JCHI vs. KURE

Last updated Jun 5, 2026

JCHI (JPMorgan Active China ETF) and KURE (KraneShares MSCI All China Health Care Index ETF) are both China Equities funds. JCHI is actively managed, while KURE is passively managed. Over the past 3 years, JCHI returned 8.99%/yr vs -6.01%/yr for KURE. A 0.68 correlation means they provide meaningful diversification when combined. Both charge a 0.65% expense ratio.

Performance

JCHI vs. KURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in JPMorgan Active China ETF (JCHI) and KraneShares MSCI All China Health Care Index ETF (KURE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, JCHI achieves a 0.50% return, which is significantly higher than KURE's -10.62% return.

JCHI

• 1D: -0.09%
• 1M: -0.31%
• YTD: 0.50%
• 6M: -0.36%
• 1Y: 16.23%
• 3Y*: 8.99%
• 5Y*: —
• 10Y*: —

KURE

• 1D: 0.07%
• 1M: -12.32%
• YTD: -10.62%
• 6M: -16.24%
• 1Y: -7.27%
• 3Y*: -6.01%
• 5Y*: -16.32%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

JCHI vs. KURE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
JCHI JPMorgan Active China ETF	0.50%	27.66%	13.77%	-17.06%
KURE KraneShares MSCI All China Health Care Index ETF	-10.62%	24.87%	-17.83%	-16.15%

Correlation

The correlation between JCHI and KURE is 0.59, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.59
Correlation (3Y) Calculated over the trailing 3-year period	0.68
Correlation (All Time) Calculated using the full available price history since Mar 17, 2023	0.68

The correlation between JCHI and KURE has been stable across timeframes, ranging from 0.59 to 0.68 - a consistent structural relationship.

JCHI vs. KURE - Sectors Allocation Comparison

Sectors	JCHI	KURE
Consumer Cyclical	20.6%	-
Financial Services	20.6%	-
Technology	14.7%	-
Communication Services	14.5%	-
Industrials	10.7%	-
Basic Materials	6.7%	-
Healthcare	4.7%	99.3%
Consumer Defensive	4.1%	0.7%
Energy	3.3%	-
Real Estate	-	-
Utilities	-	-

Return for Risk

JCHI vs. KURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JCHI

JCHI Risk / Return Rank: 25
JCHI Sharpe Ratio Rank: 26
JCHI Sortino Ratio Rank: 26
JCHI Omega Ratio Rank: 26
JCHI Calmar Ratio Rank: 25
JCHI Martin Ratio Rank: 22

KURE

KURE Risk / Return Rank: 7
KURE Sharpe Ratio Rank: 6
KURE Sortino Ratio Rank: 7
KURE Omega Ratio Rank: 7
KURE Calmar Ratio Rank: 7
KURE Martin Ratio Rank: 7

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JCHI vs. KURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for JPMorgan Active China ETF (JCHI) and KraneShares MSCI All China Health Care Index ETF (KURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	JCHI	KURE	Difference
Sharpe ratio: Return per unit of total volatility	0.93	-0.28	+1.21
Sortino ratio: Return per unit of downside risk	1.40	-0.21	+1.61
Omega ratio: Gain probability vs. loss probability	1.17	0.97	+0.20
Calmar ratio: Return relative to maximum drawdown	1.13	-0.27	+1.40
Martin ratio: Return relative to average drawdown	2.74	-0.55	+3.29
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

JCHI vs. KURE - Sharpe Ratio Comparison

The current JCHI Sharpe Ratio is 0.93, which is higher than the KURE Sharpe Ratio of -0.28. The chart below compares the historical Sharpe Ratios of JCHI and KURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	JCHI	KURE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.93	-0.28	+1.21
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.51	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.25	-0.11	+0.35

Drawdowns

JCHI vs. KURE - Drawdown Comparison

The maximum JCHI drawdown since its inception was -29.57%, smaller than the maximum KURE drawdown of -68.53%. Use the drawdown chart below to compare losses from any high point for JCHI and KURE.

Drawdown Indicators

	JCHI	KURE	Difference
Max Drawdown Largest peak-to-trough decline	-29.57%	-68.53%	+38.96%
Max Drawdown (1Y) Largest decline over 1 year	-14.37%	-27.53%	+13.16%
Max Drawdown (3Y) Largest decline over 3 years	-27.47%	-34.05%	+6.58%
Max Drawdown (5Y) Largest decline over 5 years	—	-67.94%	—
Current Drawdown Current decline from peak	-7.41%	-61.08%	+53.67%
Average Drawdown Average peak-to-trough decline	-13.33%	-38.08%	+24.75%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.93%	13.24%	-7.31%

Volatility

JCHI vs. KURE - Volatility Comparison

The current volatility for JPMorgan Active China ETF (JCHI) is 6.28%, while KraneShares MSCI All China Health Care Index ETF (KURE) has a volatility of 7.22%. This indicates that JCHI experiences smaller price fluctuations and is considered to be less risky than KURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	JCHI	KURE	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.28%	7.22%	-0.94%
Volatility (6M) Calculated over the trailing 6-month period	12.32%	17.62%	-5.30%
Volatility (1Y) Calculated over the trailing 1-year period	17.59%	26.44%	-8.85%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	24.86%	31.85%	-6.99%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	24.86%	32.38%	-7.52%

JCHI vs. KURE - Expense Ratio Comparison

Both JCHI and KURE have an expense ratio of 0.65%.

Dividends

JCHI vs. KURE - Dividend Comparison

JCHI's dividend yield for the trailing twelve months is around 1.80%, less than KURE's 4.69% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018
JCHI JPMorgan Active China ETF	1.80%	1.81%	2.12%	2.13%	0.00%	0.00%	0.00%	0.00%	0.00%
KURE KraneShares MSCI All China Health Care Index ETF	4.69%	4.19%	1.29%	0.65%	0.05%	14.12%	0.00%	0.25%	0.21%

Frequently Asked Questions

Can I hold both JCHI and KURE in my portfolio?

JCHI and KURE have a correlation of 0.59, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, JCHI or KURE?

KURE has higher volatility (7.22%) compared to JCHI (6.28%). In terms of maximum drawdown, JCHI dropped -29.57% vs KURE's -68.53%.

Which ETF is better, JCHI or KURE?

On 3-year performance, JCHI leads with 8.99% vs -6.01% for KURE. Both ETFs have the same 0.65% expense ratio. On volatility, JCHI has been the lower-risk option at 6.28%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, JCHI or KURE?

Over the 3-year period, JCHI has performed better with a 8.99% return vs -6.01%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, JCHI or KURE?

JCHI and KURE have the same expense ratio: 0.65% per year.

Which ETF pays a higher dividend yield, JCHI or KURE?

KURE has the higher dividend yield at 4.69%, compared with 1.80% for JCHI.

What is the main difference between JCHI and KURE?

They also come from different issuers: JPMorgan and CICC.

Which has better risk-adjusted returns?

JCHI currently has the higher Sharpe Ratio (0.93 vs -0.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.